NO180771C - Fremgangsmåte for fremstilling av mikrobærere dannet ved opplösningsmiddelfortynning, fremgangsmåte for fremstilling av en optisk klar opplösning, samt sårforbinding - Google Patents

Fremgangsmåte for fremstilling av mikrobærere dannet ved opplösningsmiddelfortynning, fremgangsmåte for fremstilling av en optisk klar opplösning, samt sårforbinding

Info

Publication number
NO180771C
NO180771C NO900591A NO900591A NO180771C NO 180771 C NO180771 C NO 180771C NO 900591 A NO900591 A NO 900591A NO 900591 A NO900591 A NO 900591A NO 180771 C NO180771 C NO 180771C
Authority
NO
Norway
Prior art keywords
sdmc
solvent
preparing
preparation
clear solution
Prior art date
Application number
NO900591A
Other languages
English (en)
Norwegian (no)
Other versions
NO180771B (no
NO900591D0 (no
NO900591L (no
Inventor
Michael W Fountain
Original Assignee
Fountain Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fountain Pharm Inc filed Critical Fountain Pharm Inc
Publication of NO900591D0 publication Critical patent/NO900591D0/no
Publication of NO900591L publication Critical patent/NO900591L/no
Publication of NO180771B publication Critical patent/NO180771B/no
Publication of NO180771C publication Critical patent/NO180771C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28—Microcapsules or nanocapsules
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/70—Fixation, conservation, or encapsulation of flavouring agents
    • A23L27/72—Encapsulation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Birds (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Preparation (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Materials For Medical Uses (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Distillation Of Fermentation Liquor, Processing Of Alcohols, Vinegar And Beer (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO900591A 1988-06-08 1990-02-07 Fremgangsmåte for fremstilling av mikrobærere dannet ved opplösningsmiddelfortynning, fremgangsmåte for fremstilling av en optisk klar opplösning, samt sårforbinding NO180771C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20421488A 1988-06-08 1988-06-08
PCT/US1989/002454 WO1989011850A1 (en) 1988-06-08 1989-06-08 Method for making solvent dilution microcarriers

Publications (4)

Publication Number Publication Date
NO900591D0 NO900591D0 (no) 1990-02-07
NO900591L NO900591L (no) 1990-02-07
NO180771B NO180771B (no) 1997-03-10
NO180771C true NO180771C (no) 1997-06-18

Family

ID=22757075

Family Applications (1)

Application Number Title Priority Date Filing Date
NO900591A NO180771C (no) 1988-06-08 1990-02-07 Fremgangsmåte for fremstilling av mikrobærere dannet ved opplösningsmiddelfortynning, fremgangsmåte for fremstilling av en optisk klar opplösning, samt sårforbinding

Country Status (12)

Country Link
EP (1) EP0372070B1 (de)
JP (1) JP2934889B2 (de)
KR (1) KR900701257A (de)
AT (1) ATE147622T1 (de)
AU (2) AU628355B2 (de)
CA (1) CA1340241C (de)
DE (1) DE68927669T2 (de)
ES (1) ES2013531A6 (de)
IL (1) IL90561A (de)
NO (1) NO180771C (de)
SG (1) SG45461A1 (de)
WO (1) WO1989011850A1 (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US5178875A (en) * 1991-01-14 1993-01-12 The Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
US5830498A (en) * 1987-10-16 1998-11-03 Board Of Regents, The University Of Texas System Liposomal-polyene preliposomal powder and method for its preparation
DE4136553A1 (de) * 1991-11-06 1993-05-13 Biotechnolog Forschung Gmbh Impfstoff gegen schleimhauterreger und herstellungsverfahren
WO1993013751A1 (en) * 1992-01-16 1993-07-22 Board Of Regents, The University Of Texas System Formulation and use of carotenoids in treatment of cancer
ES2145132T3 (es) * 1993-02-26 2000-07-01 Fountain Pharm Inc Sistema de suministro de vacunas y solucion precursora estable en almacenamiento para la encapsulacion a distancia de ingredientes activos.
CA2163860A1 (en) * 1993-06-30 1995-01-12 Chung C. Hsu Method for preparing liposomes
GB9423419D0 (en) * 1994-11-19 1995-01-11 Andaris Ltd Preparation of hollow microcapsules
US5660854A (en) * 1994-11-28 1997-08-26 Haynes; Duncan H Drug releasing surgical implant or dressing material
US5902604A (en) 1995-06-06 1999-05-11 Board Of Regents, The University Of Texas System Submicron liposome suspensions obtained from preliposome lyophilizates
US6884436B2 (en) 2000-12-22 2005-04-26 Baxter International Inc. Method for preparing submicron particle suspensions
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US6977085B2 (en) 2000-12-22 2005-12-20 Baxter International Inc. Method for preparing submicron suspensions with polymorph control
US20050048126A1 (en) 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
US6951656B2 (en) 2000-12-22 2005-10-04 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US7037528B2 (en) 2000-12-22 2006-05-02 Baxter International Inc. Microprecipitation method for preparing submicron suspensions
US20060003012A9 (en) 2001-09-26 2006-01-05 Sean Brynjelsen Preparation of submicron solid particle suspensions by sonication of multiphase systems
BR0212833A (pt) 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
US7112340B2 (en) 2001-10-19 2006-09-26 Baxter International Inc. Compositions of and method for preparing stable particles in a frozen aqueous matrix
US8722736B2 (en) 2007-05-22 2014-05-13 Baxter International Inc. Multi-dose concentrate esmolol with benzyl alcohol
US8426467B2 (en) 2007-05-22 2013-04-23 Baxter International Inc. Colored esmolol concentrate
JP5669058B2 (ja) * 2010-05-10 2015-02-12 独立行政法人科学技術振興機構 リポソームの製造方法
WO2012017349A2 (en) * 2010-08-02 2012-02-09 Ranbaxy Laboratories Limited An improved topical pharmaceutical composition comprising nanonized silver sulfadiazine
US9433580B2 (en) 2011-07-21 2016-09-06 Sun Pharmaceutical Industries Limited Topical pharmaceutical composition comprising nanonized silver sulfadiazine
US11298318B2 (en) 2015-04-13 2022-04-12 Fountain Technologies International, Llc One-step method for production of ultra-small lipid structures
US20240352411A1 (en) * 2023-04-20 2024-10-24 NouBio Inc. Animal-free materials for cell cultivation in bioreactors and methods of making and using thereof

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL64397A0 (en) * 1981-01-07 1982-02-28 Weder Hans G Process for the preparation of liposomal medicaments
US4556554A (en) * 1981-06-01 1985-12-03 Germaine Monteil Cosmetiques Corp. Immobilized enzymes
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
US4522803A (en) * 1983-02-04 1985-06-11 The Liposome Company, Inc. Stable plurilamellar vesicles, their preparation and use
US4588578A (en) * 1983-08-08 1986-05-13 The Liposome Company, Inc. Lipid vesicles prepared in a monophase
US4599226A (en) * 1983-03-31 1986-07-08 Genetic Laboratories, Inc. Wound dressing comprising silver sulfadiazine incorporated in animal tissue and method of preparation
CA1237671A (en) * 1983-08-01 1988-06-07 Michael W. Fountain Enhancement of pharmaceutical activity
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
US4610868A (en) * 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
FR2573308B1 (fr) * 1984-11-22 1987-01-09 Besins Iscovesco Laboratoires Procede de solubilisation, au moment de l'emploi, d'un principe actif lipophile dans une solution aqueuse, en vue de son administration par voie intraveineuse
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
US4752572A (en) * 1985-08-30 1988-06-21 Eastman Kodak Company Lipid vesicles containing labeled species and their analytical uses
EP0249561B1 (de) * 1986-06-12 1992-05-13 The Liposome Company, Inc. Mittel unter Verwendung liposomverkapselter, nichtsteroider, antiinflammatorischer Arzneistoffe
US4839175A (en) * 1986-07-28 1989-06-13 Liposome Technology, Inc. Liposomes with enhanced retention on mucosal tissue
IL97538A (en) * 1986-12-23 1995-03-15 Liposome Co Inc Multilamellar liposomes containing nonphosphate guanindino aminoglycosides and their preparation.

Also Published As

Publication number Publication date
HK1007498A1 (en) 1999-04-16
IL90561A (en) 1993-08-18
EP0372070A1 (de) 1990-06-13
JP2934889B2 (ja) 1999-08-16
EP0372070A4 (en) 1992-01-15
CA1340241C (en) 1998-12-15
IL90561A0 (en) 1990-01-18
EP0372070B1 (de) 1997-01-15
WO1989011850A1 (en) 1989-12-14
AU2719492A (en) 1993-01-07
NO180771B (no) 1997-03-10
NO900591D0 (no) 1990-02-07
DE68927669D1 (de) 1997-02-27
ATE147622T1 (de) 1997-02-15
KR900701257A (ko) 1990-12-01
NO900591L (no) 1990-02-07
JPH02504642A (ja) 1990-12-27
DE68927669T2 (de) 1997-05-07
AU628355B2 (en) 1992-09-17
ES2013531A6 (es) 1990-05-01
SG45461A1 (en) 1998-01-16
AU3777789A (en) 1990-01-05

Similar Documents

Publication Publication Date Title
NO180771C (no) Fremgangsmåte for fremstilling av mikrobærere dannet ved opplösningsmiddelfortynning, fremgangsmåte for fremstilling av en optisk klar opplösning, samt sårforbinding
ES2145298T3 (es) Preparacion de microesferas, de peliculas y de revestimientos a partir de proteinas.
DE69007691D1 (de) Verfahren zur Herstellung von Alkylaluminoxanen.
ATE147976T1 (de) Protein nanomatrizen und verfahren zur herstellung
DE59005714D1 (de) Verfahren zur Herstellung wässriger Polymerisatdispersionen.
DE69014186D1 (de) Verfahren zur Herstellung von Detergenszubereitungen mit hoher Schüttdichte.
DE68912657D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan.
DE69006951D1 (de) Verfahren zur Herstellung von 1,1,1,2-Tetrafluorethan.
ATE149826T1 (de) Verfahren zur herstellung von festen pharmazeutischen retardformen
DE69023529D1 (de) Verfahren zur Behandlung von wässerigen Fermentationsbrühen.
DE69003009D1 (de) Verfahren zur Behandlung von Fasermaterialien.
DE59003447D1 (de) Verfahren zur Herstellung von Benztriazolen.
DE58907083D1 (de) Verfahren zur Herstellung von Benztriazolderivaten.
ATE100442T1 (de) Verfahren zur konzentrierung von harnstoffloesungen unter vakuum.
ATE92075T1 (de) Verfahren zur gewinnung aktiver proteine aus einer biologisch inaktiven form.
DE69013429D1 (de) Verfahren zur Herstellung von 2,2-Dimethyl-3-hydroxypropyl-2,2-dimethyl-3-hydroxypropionat.
DE59100382D1 (de) Verfahren zur Reinigung von wässerigen N-Methylmorpholin-N-oxid-Lösungen.
DE59101189D1 (de) Verfahren zur Herstellung von Chinophthalonen.
ATE29664T1 (de) Herstellung von deutlich vertieft gepraegten gegenstaenden.
DE69309885D1 (de) Verfahren zur Herstellung wässriger Lösungen von quaternären Ammoniumhydroxiden
DE69812645D1 (de) Verfahren zur herstellung von kontrastmitteln
DE58909195D1 (de) Verfahren zur Herstellung von wässrigen Formaldehydlösungen.
ATE51398T1 (de) Verfahren zur herstellung von 4,4'-dinitrostilben-2,2'-disulfonsaeure.
DE69016857D1 (de) Verfahren zur Herstellung von NiNi-Diakyl- 1,8-Naphthalendiamin.
DE58909397D1 (de) Verfahren zur Herstellung von 4-Hydroxy-1,2,2,6,6-pentamethylpiperidin.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees